In this issue:
Pharmacogenomic testing
ECT and risk of suicide death:
Canadian study
US study
Quetiapine: depressive and anxiety disorders
Antidepressant resistance in late-onset MDD
Opioid use disorder:
Depression and relapse during buprenorphine/naloxone
Antidepressants and buprenorphine discontinuation
Vortioxetine: supratherapeutic dosing
Dextromethorphan-bupropion in MDD
Clinical depression and dementia
Please login below to download this issue (PDF)